RESUMO
Several potent and efficacious MCHr1 antagonists containing an ortho-amino benzamide or nicotinamide chemotype have been identified, exemplified by 28 and 50.
Assuntos
Niacinamida/análogos & derivados , Receptores de Somatostatina/antagonistas & inibidores , ortoaminobenzoatos/síntese química , Animais , Benzamidas/síntese química , Benzamidas/farmacocinética , Benzamidas/farmacologia , Concentração Inibidora 50 , Camundongos , Camundongos Endogâmicos , Niacinamida/farmacocinética , Niacinamida/farmacologia , Farmacocinética , Receptores de Somatostatina/agonistas , Relação Estrutura-Atividade , Distribuição Tecidual , ortoaminobenzoatos/farmacocinética , ortoaminobenzoatos/farmacologiaRESUMO
An efficient and highly enantioselective (>/=92% ee) catalytic method for conjugate addition of alkylzinc reagents to cyclic nitroalkenes is reported. Reactions are promoted in the presence of 0.5-5 mol % (CuOTf)2.C6H6 and 1-10 mol % of chiral amino acid-based phosphine ligands at 0 degrees C in toluene. The Cu-catalyzed reactions can be effectively carried out with small-, medium-, and large-ring nitroalkenes. Depending on the reaction conditions used, either the nitro or the corresponding alpha-substituted ketone product can be readily accessed by the present protocol.
Assuntos
Alcenos/química , Cobre/química , Hidrocarbonetos Cíclicos/síntese química , Cetonas/síntese química , Nitrocompostos/química , Compostos Organometálicos/química , Catálise , Cicloexanos/química , Cicloexenos , Hidrocarbonetos Cíclicos/químicaRESUMO
Highest enantioselectivities so far with dialkylzinc reagents! Quaternary carbon centers are formed enantioselectively through a Cu-catalyzed allylic substitution reaction that is promoted by pyridinyl peptide-based ligands in the presence of dialkylzinc reagents. The modularity of this new class of chiral ligands is exploited for reactivity and selectivity optimization.